Cancer stem cells (CSCs) Promising results from clinical trials of CSC inhibitors have confirmed CSCs as therapeutic targets. ONC201 is a first-in-class anticancer small molecule in phase I/II clinical trials for advanced cancer. We have previously shown that ONC201 targets the self-renewal of chemotherapy-resistant colorectal CSCs by inhibiting Akt/ERK and inducing DR5/TRIL.
Contact us:
Quick access:
Tajhiz Salamat Eram, is a provider of quality medical equipment and specialized consulting services, professional maintenance and repair. In the footer section of the site, take advantage of contact information, support services, and ways to communicate with us. Contact us now for consultation and purchase of medical equipment suitable for your needs.
all rights reserved by Tajhiz Salamat Eram Company.
Website design: Rikan Tech